Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
Tarsus Pharmaceuticals (NASDAQ: TARS) has scheduled its third quarter 2024 financial results announcement and corporate update for Wednesday, November 13, 2024, at 1:30 p.m. PT / 4:30 p.m. ET. The company will host a live webcast of the event, which will be archived on their website for approximately 90 days following the presentation.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha programmato l'annuncio dei risultati finanziari del terzo trimestre 2024 e un aggiornamento aziendale per mercoledì 13 novembre 2024, alle 13:30 ora del Pacifico / 16:30 ora orientale. L'azienda ospiterà una diretta streaming dell'evento, che sarà archiviata sul loro sito web per circa 90 giorni dopo la presentazione.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 y una actualización corporativa para el miércoles 13 de noviembre de 2024, a la 1:30 p.m. PT / 4:30 p.m. ET. La empresa llevará a cabo una transmisión en vivo del evento, que se archivará en su sitio web durante aproximadamente 90 días después de la presentación.
Tarsus Pharmaceuticals (NASDAQ: TARS)는 2024년 3분기 재무 결과 발표 및 기업 업데이트를 2024년 11월 13일 수요일, 태평양 표준시 오후 1:30 / 동부 표준시 오후 4:30에 예정했습니다. 회사는 이 이벤트의 실시간 웹 중계를 진행하며, 발표 후 약 90일 동안 웹사이트에 아카이브할 예정입니다.
Tarsus Pharmaceuticals (NASDAQ: TARS) a prévu l'annonce de ses résultats financiers du troisième trimestre 2024 et d'une mise à jour de l'entreprise pour le mercredi 13 novembre 2024, à 13h30 PT / 16h30 ET. L'entreprise organisera une diffusion en direct de l'événement, qui sera archivée sur leur site Web pendant environ 90 jours après la présentation.
Tarsus Pharmaceuticals (NASDAQ: TARS) hat die Bekanntgabe der Finanzergebnisse für das dritte Quartal 2024 und ein Unternehmensupdate für Mittwoch, den 13. November 2024, um 13:30 Uhr PT / 16:30 Uhr ET angesetzt. Das Unternehmen wird eine Live-Übertragung der Veranstaltung anbieten, die etwa 90 Tage nach der Präsentation auf ihrer Website archiviert wird.
- None.
- None.
IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, November 13, 2024 to report its third quarter 2024 financial results and provide a corporate update.
Participants may access the webcast here. A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution)
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com
FAQ
When will Tarsus Pharmaceuticals (TARS) report Q3 2024 earnings?
How can I access Tarsus Pharmaceuticals (TARS) Q3 2024 earnings webcast?
How long will Tarsus Pharmaceuticals (TARS) Q3 2024 earnings call recording be available?
